Pembrolizumab Monotherapy Effective for Rare Melanoma

Pembrolizumab led to a dramatic overall response rate among patients with unresectable desmoplastic melanoma.
MDedge News

source https://www.medscape.com/viewarticle/990945?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?